Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Transferrin conjugates in the anticancer therapy].

Dorota Lubgan1, Agnieszka Marczak, Luitpold Distel

  • 1Katedra Termobiologii, Uniwersytet Lódzki, Lódź. lubgan1@poczta.onet.pl

Postepy Biochemii
|July 28, 2006
PubMed
Summary

Transferrin shows promise as a drug carrier for cancer therapy. It targets cancer cells via transferrin receptors, enhancing drug efficacy and reducing side effects on healthy cells.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Breast cancer risk genes affecting individual radiosensitivity.

Scientific reports·2026
Same author

Liposomal Vitamin C as a Modulator of the Efficacy of Ceralasertib Therapy in Ovarian Cancer.

International journal of molecular sciences·2026
Same author

Persons with epilepsy have an elevated radiosensitivity, which may be mitigated by folic acid.

Journal of neurology·2026
Same author

Erratum: Benefit of Chemoradiotherapy Versus Chemotherapy After Induction Therapy for Conversion of Unresectable Into Resectable Pancreatic Cancer: The Randomized CONKO-007 Trial.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2026
Same author

Paclitaxel-Loaded Polyelectrolyte Nanocarriers: Uptake Mechanisms, Cytotoxicity, and Genotoxicity in Human Endothelial and Breast Cancer Cells.

Nanotechnology, science and applications·2025
Same author

Nanoparticle-Mediated Ferroptosis for Cancer Therapy: Mechanisms and Therapeutic Strategies.

Nanotechnology, science and applications·2025

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Context:

  • Anticancer drug therapy often faces challenges with efficacy and systemic side effects.
  • Drug delivery systems are crucial for targeted cancer treatment.
  • Transferrin receptors are upregulated in neoplastic cells.

Purpose:

  • To explore the potential of transferrin as a targeted drug delivery vehicle for cancer therapy.
  • To leverage the specific binding of transferrin to cancer cells for improved drug targeting.

Summary:

  • Transferrin, a promising protein, can act as a carrier for drugs, DNA, and ions.
  • Its ability to bind to upregulated transferrin receptors on cancer cells allows for targeted delivery.
  • This targeted approach aims to deliver therapeutic agents directly to neoplastic cells, sparing normal cells.

Related Experiment Videos

Impact:

  • Potential to enhance the therapeutic efficacy of anticancer drugs.
  • Significant reduction in systemic side effects associated with conventional chemotherapy.
  • Development of novel targeted cancer treatment strategies.